showed that miR-526b-3p attenuates breast cancer stem cell characteristics and chemotherapy resistance by targeting HIF-2α/Notch signaling pathway, which may be used to alleviate chemotherapy resistance in breast cancer (85). This evidence concerns the gene EPAS1 and breast carcinoma.